A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy. [electronic resource]
Producer: 20200701Description: 363-372 p. digitalISSN:- 1097-0142
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Hepatocellular -- mortality
- Dose Fractionation, Radiation
- Female
- Humans
- Liver Neoplasms -- mortality
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- mortality
- Progression-Free Survival
- Prospective Studies
- Radiation Injuries -- epidemiology
- Radiosurgery -- adverse effects
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.